Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide Donors for Isolated Oligohydramnios
NCT02712125Phase 3Completed
- Sponsor
- Benha University
- Start
- Aug 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Oligohydramnios (Oligo) comparing Isosorbide Mononitrate with Placebo (2 arms). Primary endpoint: Change in Amniotic Fluid Index up to 40 weeks. Started Aug 2013; status: completed.
02
Drugs
isosorbide mononitrate
03
Conditions
Oligohydramnios (Oligo)
Beyond the preview
Go deeper on NCT02712125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02712125.